Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome
Clinical and Molecular Hepatology
; : 417-420, 2013.
Article
in En
| WPRIM
| ID: wpr-34823
Responsible library:
WPRO
ABSTRACT
Terlipressin is a vasopressin analogue that is widely used in the treatment of hepatorenal syndrome or variceal bleeding. Because it acts mainly on splanchnic vessels, terlipressin has a lower incidence of severe ischemic complications than does vasopressin. However, it can still lead to serious complications such as myocardial infarction, skin necrosis, or bowel ischemia. Herein we report a case of severe ischemic bowel necrosis in a 46-year-old cirrhotic patient treated with terlipressin. Although the patient received bowel resection, death occurred due to ongoing hypotension and metabolic acidosis. Attention should be paid to patients complaining of abdominal pain during treatment with terlipressin.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Vasoconstrictor Agents
/
Bilirubin
/
Hepatorenal Syndrome
/
Lypressin
/
Tomography, X-Ray Computed
/
Fatal Outcome
/
Creatinine
/
Electrocardiography
/
Intestinal Mucosa
/
Intestines
Limits:
Humans
/
Male
Language:
En
Journal:
Clinical and Molecular Hepatology
Year:
2013
Type:
Article